Adamas Pharma (ADMS) Lower on $50M Stock Offering
Tweet
Share
E-mailGet Alerts ADMS Hot Sheet
Join SI Premium – FREE
Adamas Pharma (NASDAQ: ADMS) is lower after the company filed a prospectus covering $50 million in common stock. Shares will be offered through Cowen.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FibroBiologics closes $3M private placement with warrant upside
- Energous Wireless Power added to Russell 3000 and 2000 indexes
- AMASS Brands to acquire majority stake in HpO sparkling protein water
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
